The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Magnetic Resonance Spectroscopy Studies of Glutamate-Related Abnormalities in Mood Disorders
Open accessAbstract
In mood disorders there is growing evidence for glutamatergic abnormalities derived from peripheral measures of glutamatergic metabolites in patients, postmortem studies on glutamate related markers, and animal studies on the mechanism of action of available treatments. Magnetic resonance spectroscopy (MRS) has the potential to corroborate and extend these findings with the advantage of in vivo assessment of glutamate-related metabolites in different disease states, in response to treatment, and in relation with functional imaging data. In this article we first review the biological significance of glutamate, glutamine, and Glx (composed mainly of glutamate and glutamine). Next we review the MRS literature in mood disorders examining these glutamate-related metabolites. Here, we find a highly consistent pattern of Glx level reductions in major depressive disorder and elevations in bipolar disorder. In addition, studies of depression regardless of diagnosis provide suggestive evidence for reduced glutamine/glutamate ratio, and in mania for elevated glutamine/glutamate ratio. These patterns suggest that the glutamate-related metabolite pool (not all of it necessarily relevant to neurotransmission) is constricted in major depressive disorder and expanded in bipolar disorder. Depressive and manic episodes may be characterized by modulation of the glutamine/glutamate ratio in opposite directions, possibly suggesting reduced vs. elevated glutamate conversion to glutamine by glial cells, respectively. We discuss the implications of these results for the pathophysiology of mood disorders, and suggest future directions for MRS studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 2×
“In postmortem studies, glial cell number and density reduction is consistently demonstrated in mood disorders in the subgenual prefrontal cortex [47], orbitofrontal cortex [48], supracallosal anterior cingulate cortex [49], dorsolateral prefrontal cortex [50] and amygdala [51,52].”
BackgroundSelf-citationRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 1×
“In postmortem studies, glial cell number and density reduction is consistently demonstrated in mood disorders in the subgenual prefrontal cortex [47], orbitofrontal cortex [48], supracallosal anterior cingulate cortex [49], dorsolateral prefrontal cortex [50] and amygdala [51,52].”
BackgroundMathers, C. (2008) · International Encyclopedia of Public Health · doi:10.1016/b978-012373960-5.00335-x · Cited by 1,121
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Metabolism and role of glutamate in mammalian brain
Erecińska, M., & Silver, I. A. (1990) · Progress in Neurobiology · doi:10.1016/0301-0082(90)90013-7 · Cited by 682
Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., Myers, R. M., Bunney, W. E., Akil, H., Watson, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507901102 · Cited by 652
Increased Levels of Glutamate in Brains from Patients with Mood Disorders
Hashimoto, K., Sawa, A., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.017 · Cited by 609
Baxter, L. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790280019002 · Cited by 603
Rajkowska, G., Halaris, A., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 570
Auer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 564
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., Epperson, C. N., Goddard, A., & Mason, G. F. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001021 · Cited by 553
Low glial numbers in the amygdala in major depressive disorder
Bowley, M. P., Drevets, W. C., Öngür, D., & Price, J. L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01404-x · Cited by 503
Self-citationAstrocytic control of glutamatergic activity: astrocytes as stars of the show
Hertz, L., & Zielke, H. R. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.10.008 · Cited by 470
Glial cell abnormalities in major psychiatric disorders: the evidence and implications
Cotter, D. R., Pariante, C. M., & Everall, I. P. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00527-5 · Cited by 465
Astrocytes: Glutamate producers for neurons
Hertz, L., Dringen, R., Schousboe, A., & Robinson, S. R. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990815)57:4<417::aid-jnr1>3.0.co;2-n · Cited by 456
Brain Metabolic Alterations in Medication-Free Patients With BipolarDisorder
Dager, S. R., Friedman, S. D., Parow, A., Demopulos, C., Stoll, A. L., Lyoo, I. K., Dunner, D. L., & Renshaw, P. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.450 · Cited by 453
Théberge, J., Bartha, R., Drost, D. J., Menon, R. S., Malla, A., Takhar, J., Neufeld, R. W., Rogers, J., Pavlosky, W., Schaefer, B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1944 · Cited by 398
Glutamate-based antidepressants: 20 years on
Skolnick, P., Popik, P., & Trullas, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.09.002 · Cited by 380
Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes
Hamidi, M., Drevets, W. C., & Price, J. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.006 · Cited by 369 · cited 1×
“In postmortem studies, glial cell number and density reduction is consistently demonstrated in mood disorders in the subgenual prefrontal cortex [47], orbitofrontal cortex [48], supracallosal anterior cingulate cortex [49], dorsolateral prefrontal cortex [50] and amygdala [51,52].”
BackgroundSkolnick, P., Layer, R., Popik, P., Nowak, G., Paul, I., & Trullas, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979537 · Cited by 344
Rothman, D. L., Behar, K. L., Hyder, F., & Shulman, R. G. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142131 · Cited by 337
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Walter, M., Henning, A., Grimm, S., Schulte, R. F., Beck, J., Dydak, U., Schnepf, B., Boeker, H., Boesiger, P., & Northoff, G. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.39 · Cited by 306
Bhagwagar, Z., Wylezinska, M., Jezzard, P., Evans, J., Ashworth, F., Sule, A., Matthews, P. M., & Cowen, P. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.048 · Cited by 303
Pfleiderer, B., Michael, N., Erfurth, A., Ohrmann, P., Hohmann, U., Wolgast, M., Fiebich, M., Arolt, V., & Heindel, W. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(03)00003-9 · Cited by 301
Fekadu, A., Wooderson, S. C., Markopoulo, K., Donaldson, C., Papadopoulos, A., & Cleare, A. J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.014 · Cited by 299
Beyond Monoamines: Glutamatergic Function in Mood Disorders
Kugaya, A., & Sanacora, G. (2005) · CNS Spectrums · doi:10.1017/s1092852900010403 · Cited by 290
Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania
Öngür, D., Jensen, J. E., Prescot, A. P., Stork, C., Lundy, M., Cohen, B. M., & Renshaw, P. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.014 · Cited by 270
Self-citationPrice, R. B., Shungu, D. C., Mao, X., Nestadt, P., Kelly, C., Collins, K. A., Murrough, J. W., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.025 · Cited by 270
MICHAEL, N., ERFURTH, A., OHRMANN, P., AROLT, V., HEINDEL, W., & PFLEIDERER, B. (2003) · Psychological Medicine · doi:10.1017/s0033291703007931 · Cited by 260
Beneyto, M., & Meador-Woodruff, J. H. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301604 · Cited by 259
Zarate, C. A., Quiroz, J. A., Singh, J. B., Denicoff, K. D., De Jesus, G., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.023 · Cited by 257
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., Miklowitz, D. J., Miyahara, S., Bauer, M. S., Thase, M. E., Wisniewski, S. R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.210 · Cited by 257
The burden of depression and anxiety in general medicine.
Lecrubier, Y. (2001) · PubMed · Cited by 245
Plasma and platelet excitatory amino acids in psychiatric disorders
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1731 · Cited by 243
Increased cerebrospinal fluid glutamine levels in depressed patients
Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00284-x · Cited by 240 · cited 1×
“Cerebrospinal fluid glutamate levels were found to be high or normal in patients with major depressive disorder [42,43], and low in a mixed group with bipolar disorder and major depressive disorder patients [44].”
BackgroundSibson, N. R., Mason, G. F., Shen, J., Cline, G. W., Herskovits, A. Z., Wall, J. E. M., Behar, K. L., Rothman, D. L., & Shulman, R. G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00074.x · Cited by 238
Bonanno, G., Giambelli, R., Raiteri, L., Tiraboschi, E., Zappettini, S., Musazzi, L., Raiteri, M., Racagni, G., & Popoli, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5033-04.2005 · Cited by 234
Mauri, M. C., Ferrara, A., Boscati, L., Bravin, S., Zamberlan, F., Alecci, M., & Invernizzi, G. (1998) · Neuropsychobiology · doi:10.1159/000026491 · Cited by 231
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
Law, A. J., & Deakin, J. F. W. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00043 · Cited by 227
Increased Anterior Cingulate/Medial Prefrontal Cortical Glutamate and Creatine in Bipolar Depression
Frye, M. A., Watzl, J., Banakar, S., O'Neill, J., Mintz, J., Davanzo, P., Fischer, J., Chirichigno, J. W., Ventura, J., Elman, S., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301387 · Cited by 222
Michael, N., Erfurth, A., Ohrmann, P., Arolt, V., Heindel, W., & Pfleiderer, B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300085 · Cited by 208
Sanacora, G., Kendell, S. F., Levin, Y., Simen, A. A., Fenton, L. R., Coric, V., & Krystal, J. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.037 · Cited by 199
Schousboe, A. (2003) · Neurochemical Research · doi:10.1023/a:1022397704922 · Cited by 199
Altamura, C., Maes, M., Dai, J., & Meltzer, H. Y. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00033-l · Cited by 193
Increased serum glutamate in depressed patients
Kim, J. S., Schmid-Burgk, W., Claus, D., & Kornhuber, H. H. (1982) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00345492 · Cited by 189
Michael, N., Erfurth, A., Ohrmann, P., G�ssling, M., Arolt, V., Heindel, W., & Pfleiderer, B. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1440-z · Cited by 187
Maes, M., Verkerk, R., Vandoolaeghe, E., Lin, A., & Scharpé, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10004.x · Cited by 179
Lan, M. J., McLoughlin, G. A., Griffin, J. L., Tsang, T. M., Huang, J. T. J., Yuan, P., Manji, H., Holmes, E., & Bahn, S. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002130 · Cited by 178
Boyer, P., Skolnick, P., & Fossom, L. H. (1998) · Journal of Molecular Neuroscience · doi:10.1007/bf02761776 · Cited by 171
Brennan, B. P., Hudson, J. I., Jensen, J. E., McCarthy, J., Roberts, J. L., Prescot, A. P., Cohen, B. M., Pope, H. G., Renshaw, P. F., & Öngür, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.191 · Cited by 168
Self-citationLow Cerebrospinal Fluid Glutamate and Glycine in Refractory Affective Disorder
Frye, M. A., Tsai, G. E., Huggins, T., Coyle, J. T., & Post, R. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.024 · Cited by 166
Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder
McCullumsmith, R. E., Kristiansen, L. V., Beneyto, M., Scarr, E., Dean, B., & Meador‐Woodruff, J. H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.011 · Cited by 162
Block, W., Träber, F., von Widdern, O., Metten, M., Schild, H. H., Maier, W., Zobel, A. W., & Jessen, F. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009516 · Cited by 162
Meador‐Woodruff, J. H., Hogg, A. J., & Smith, R. E. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00523-8 · Cited by 154
Paulsen, R. E., & Fonnum, F. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07263.x · Cited by 152
CYLOSERINE AS AN ANTIDEPRESSANT AGENT
CRANE, G. E. (1959) · American Journal of Psychiatry · doi:10.1176/ajp.115.11.1025 · Cited by 127
Frey, B. N., Stanley, J. A., Nery, F. G., Monkul, E. S., Nicoletti, M., Chen, H., Hatch, J. P., Caetano, S. C., Ortíz, O., Kapczinski, F. P., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00454.x · Cited by 125
Beneyto, M., & Meador‐Woodruff, J. H. (2006) · Synapse · doi:10.1002/syn.20329 · Cited by 124
Hasler, G., Neumeister, A., van der Veen, J. W. C., Tumonis, T., Bain, E., Shen, J., Drevets, W. C., & Charney, D. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.017 · Cited by 122
AMPA Receptors in the Therapeutic Management of Depression
Bleakman, D., Alt, A. J., & Witkin, J. M. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363258 · Cited by 115
Waagepetersen, H. S., Qu, H., Sonnewald, U., Shimamoto, K., & Schousboe, A. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.012 · Cited by 111
Michael-Titus, A. T., Bains, S., Jeetle, J. K., & Whelpton, R. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00390-0 · Cited by 109
Lyoo, I. K., Yoon, S. J., Musen, G., Simonson, D. C., Weinger, K., Bolo, N. R., Ryan, C. M., Kim, J. E., Renshaw, P. F., & Jacobson, A. M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.86 · Cited by 108
Colla, M., Schubert, F., Bubner, M., Heidenreich, J. O., Bajbouj, M., Seifert, F., Luborzewski, A., Heuser, I., & Kronenberg, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.26 · Cited by 106 · cited 2×
“Glutamate was elevated in the hippocampus in euthymic subjects and in postmortem samples from DLPFC of individuals with BD [74,77].”
BackgroundBarbon, A., Popoli, M., Via, L. L., Moraschi, S., Vallini, I., Tardito, D., Tiraboschi, E., Musazzi, L., Giambelli, R., Gennarelli, M., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.018 · Cited by 104
Magnetic Resonance Spectroscopy and its Applications in Psychiatry
Malhi, G. S., Valenzuela, M., Wen, W. X., & Sachdev, P. S. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.00992.x · Cited by 104
Schwartz, J. M. (1987) · JAMA · doi:10.1001/jama.258.10.1368 · Cited by 100
Francis, P. T., Poynton, A., Lowe, S. L., Najlerahim, A., Bridges, P. K., Bartlett, J. R., PROCTER, A. W., Bruton, C. J., & Bowen, D. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)90600-8 · Cited by 96
Senaratne, R., Milne, A. M., MacQUEEN, G. M., & Hall, G. B. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.07.007 · Cited by 92
Iltis, I., Koski, D. M., Eberly, L. E., Nelson, C. D., Deelchand, D. K., Valette, J., Uǧurbil, K., Lim, K. O., & Henry, P. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1385 · Cited by 92
Targeting glial physiology and glutamate cycling in the treatment of depression
Valentine, G. W., & Sanacora, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.008 · Cited by 92
Milne, A. M., MacQUEEN, G. M., Yücel, K., Soreni, N., & Hall, G. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.03.031 · Cited by 92
Port, J. D., Unal, S. S., Mrazek, D. A., & Marcus, S. M. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.08.004 · Cited by 91
Alteration of Striatal Glutamate Release After Glutamine Synthetase Inhibition
Rothstein, J. D., & Tabakoff, B. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05406.x · Cited by 86
Elevated Levels of the NR2C Subunit of the NMDA Receptor in the Locus Coeruleus in Depression
Karolewicz, B., Stockmeier, C. A., & Ordway, G. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300781 · Cited by 81
Neurochemistry of late‐life major depression: A pilot two‐dimensional MR spectroscopic study
Binesh, N., Kumar, A., Hwang, S., Mintz, J., & Thomas, M. A. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20214 · Cited by 76
Riluzole Augmentation for Treatment-Resistant Depression
Sanacora, G., Kendell, S. F., Fenton, L. R., Coric, V., & Krystal, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2132 · Cited by 72
Mlynárik, V., Kohler, I., Gambarota, G., Vaslin, A., Clarke, P. G. H., & Rolf Gruetter, A. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21447 · Cited by 71
Keshavan, M. S., Kapur, S., & Pettegrew, J. W. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.976 · Cited by 67
Xu, S., Yang, J., Li, C. Q., Zhu, W., & Shen, J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.06.016 · Cited by 60
Igarashi, H., Kwee, I. L., Nakada, T., Katayama, Y., & Terashi, A. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02579-3 · Cited by 55
Kanamori, K., Ross, B. D., & Kondrat, R. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01161.x · Cited by 52
Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder
Michael, N., Erfurth, A., & Pfleiderer, B. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.01.002 · Cited by 46
Lamotrigine Augmentation Strategy for Patients with Treatment-Resistant Depression
Gutierrez, R., McKercher, R. M., Galea, J., & Jamison, K. L. (2005) · CNS Spectrums · doi:10.1017/s1092852900010324 · Cited by 41
Lamotrigine in the treatment of bipolar disorder
Bhagwagar, Z., & Goodwin, G. M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1401 · Cited by 26
Pangalos, M. N., Malizia, A. L., Francis, P. T., Lowe, S. L., Bertolucci, P. H. F., PROCTER, A. W., Bridges, P. K., Bartlett, J. R., & Bowen, D. M. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.160.5.638 · Cited by 22
The differential diagnosis of depression.
Folkson, A. (1960) · PubMed · Cited by 17
Cited by
Snyder, H. R. (2013) · Psychological Bulletin · doi:10.1037/a0028727 · Cited by 1,667
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
“In BPD and OCD, data suggest CNS cortical hyperglutamatergia in both disorders (Table 2) [78,84,88,131].”
InfluentialTargeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482
Metadata
- Authors
- Yüksel, C., & Öngür, D.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 68
- Issue
- 9
- Pages
- 785-794
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2040344668
- Cited by
- 493
- References
- 98
- FWCI
- 18.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.